 |
|
Cell Therapies, through the Centre for Blood Cell Therapy combines leading scientists and researchers. Our academic institute brings substantial expertise in fundamental research to any clinical trial, and therefore the potential to add value to research collaborations.
The staff of Cell Therapies | 
Fully integrated multi-modality imaging facility and a GMP/TGA licensed facility deliver critical new information about the fate of transplanted cells.
Tracking studies utilizing labelled cells |
Peter Mac was the first cGMP and Therapeutic Goods Administration-accredited laboratory in Australia. The TGA is a unit of the Federal Government which is responsible for administering the provisions of the Australian legislation for blood and related bio-materials.
Peter Mac's CBCT facilities |
Cell Therapies Pty Ltd
Cell Therapies P/L Secures Additional NCRIS Subsidies for cGMP Compliant Manufacturing | July 2009
Cell Therapies Pty Ltd is pleased to announce that it has recently been awarded new subsidies under the Federal Governments NCRIS scheme. These new subsidies are directed towards CT is in the business of planning and conducting clinical trials
that involve the collection, manipulation and storage of blood cells and human tissue. The services range from laboratory rental through to fully-integrated planning and execution of clinical trials that involve cellular therapeutics manufactured in code of Good Manufacturing Practice (cGMP) and Therapeutic Goods Administration (TGA) licensed facilities.
More about Cell Therapies |
The Centre for Blood Cell Therapy has worked collaboratively with the Therapeutic Goods Administration and others, including the Gene Manipulation Advisory Committee and the Gene Therapy Research Advisory Panel of the National Health and Medical Research Council to ensure on-going compliance with the evolving standards for cell and tissue therapies.
Adhering to international standards | |
|
